PubMed Health⌕ Search

PubMed · 12378979

[Arterial pulse pressure].

Abstract

A WELL IDENTIFIED RISK FACTOR: Other than systolic, diastolic and mean pressure, arterial pulse pressure (or differential pressure) is an independent factor of cardiovascular and notably coronary risk. The role of this factor is now clearly quantified in untreated hypertensive patients, but also in treated apparently controlled patients, and in patients with normal blood pressure. Demonstration of the deleterious role of an increase in pulse pressure was also made in populations at high risk of events such as heart failure, post-infarction or in hemodialyzed patients. FROM A THERAPEUTIC POINT OF VIEW: Antihypertensive treatments have inconstant efficacy on pulse pressure and new therapeutic routes appear promising. However, in the absence of available proof that a strategy axed on the decrease in pulse pressure improves cardiovascular prognosis, current recommendations do not yet include pulse pressure levels in therapeutic strategies. AN EFFICIENT MARKER: Whilst awaiting further data, the measurement of pulse pressure, because of its pertinence and simplicity, provides the practitioner with one of the most efficient markers for screening persons at high risk of cardiovascular and particularly coronary risk.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jean-Jacques Mourad. 2002-09-21. [Arterial pulse pressure].. https://pubmed.ncbi.nlm.nih.gov/12378979/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A method for comparing two normal means using combined samples of correlated and uncorrelated data.

A method is proposed for comparing two normal means when the data consist of some observations that are correlated and others that are uncorrelated. Typically, such data will consist of one subsample in which the observations for treatment 1 and treatment 2 are independent of each other, and another subsample which consists of paired observations taken under both treatments. The proposed method is developed using asymptotic results and is evaluated using simulation. The simulation results indicate that the proposed method can provide substantial improvement in type I error rate and power when compared with standard methods of analysis.

Antihypertensive Agents↗

Optimization of a solid-phase extraction method for determination of indapamide in biological fluids using high-performance liquid chromatography.

A new simple and rapid high-performance liquid chromatographic (HPLC) method with UV detection for the determination of indapamide in biological fluids has been developed. Indapamide and internal standard were isolated from serum and whole blood samples by solid-phase extraction with RP select B cartridges. The chromatographic separation was accomplished on a reversed-phase C(8) column with a mobile phase composed of 0.1% (v/v) triethylamine in water (pH 3.5) and acetonitrile (63:37, v/v). UV detection was set at 240 nm. The calibration curves were linear in the concentration range of 10.0-100.0 ng/ml for serum, and 50.0-500.0 ng/ml for whole blood, and the limits of quantification were 10.0 and 50.0 ng/ml, respectively.

Antihypertensive Agents↗